A Novel Artificial Intelligence-Powered Method for Prediction of Early Recurrence of Prostate Cancer After Prostatectomy and Cancer Drivers.

Huang, Wei; Randhawa, Ramandeep; Jain, Parag; Hubbard, Samuel; Eickhoff, Jens; Kummar, Shivaani; Wilding, George; Basu, Hirak; Roy, Rajat

Huang, Wei; Randhawa, Ramandeep; Jain, Parag; Hubbard, Samuel; Eickhoff, Jens; Kummar, Shivaani; Wilding, George; Basu, Hirak; Roy, Rajat.

Afiliación

Huang W; Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI.
Randhawa R; PathomIQ, Inc, Cupertino, CA.
Jain P; PathomIQ, Inc, Cupertino, CA.
Hubbard S; University of Southern California Marshall School of Business, Los Angeles, CA.
Eickhoff J; PathomIQ, Inc, Cupertino, CA.
Kummar S; Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI.
Wilding G; Department of Biostatistics and Informatics, University of Wisconsin-Madison, Madison, WI.
Basu H; PathomIQ, Inc, Cupertino, CA.
Roy R; Division of Hematology & Medical Oncology, Center for Experimental Therapeutics, Knight Cancer Institute, Oregon Health & Science University, Portland, OR.

JCO Clin Cancer Inform ; 6: e2100131, 2022 02.

Article en En | MEDLINE | ID: mdl-35192404

Asunto(s)

Inteligencia Artificial; Neoplasias de la Próstata; Humanos; Masculino; Próstata/patología; Antígeno Prostático Específico; Prostatectomía/métodos; Neoplasias de la Próstata/diagnóstico; Neoplasias de la Próstata/cirugía

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Inteligencia Artificial Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: JCO Clin Cancer Inform Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google